Clinical trials

What reforms are needed for the EU clinical trials directive

Interviewee/Contributer: Kate Law

Organisation: Cancer Research UK

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The outlook for new clinical trial legislation in Europe

Interviewee/Contributer: Karen Finn

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How cannabis medicines gained legitimacy

Interviewee/Contributer: Roger Pertwee

Organisation: University of Aberdeen

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Denmark has introduced new procedures for ADRs

Interviewee/Contributer: Henrik Jensen

Organisation: Danish Medicines Agency

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Finding solutions to drug resistance

Interviewee/Contributer: Laura Smart

Organisation: Tiber Creek Partners LLC

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Analysis of Special Protocol Assessments for oncology

Interviewee/Contributer: Bruno Pagliara

Organisation: On-Kòs Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Drug development – travelling together?

Interviewee/Contributer: Jytte Lyngvig

Organisation: Danish Medicines Agency

Full text available to subscribers only. Click here for information on subscribing to MedNous.

What’s next for the EU Clinical Trials Directive?

Interviewee/Contributer: Ingrid Klingmann.

Organisation: European Forum for Good Clinical Practice

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Clinical trials in the UK

Interviewee/Contributer: Philip Wright

Organisation: ST&I Partners LLP

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Sygnis Pharma's New Approach

Interviewee/Contributer: Alfred Bach

Organisation: Sygnis Pharma AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content